Next-Generation Sequencing

Studying causal genes and their expression in Alzheimer's disease research
Next-generation sequencing (NGS) is rapidly changing the paradigm for research into disease causes, progression, treatment, and diagnosis, by allowing analysis of multiple genes in a single test. DNA sequencing to identify genes associated with disease, or RNA sequencing to look at gene expression in disease and normal states, will shed light on factors that cause Alzheimer's disease and those that influence its progression and outcome. NGS solutions from QIAGEN enable outstanding results on any sequencing platform.